相关实验视频

Updated: Jun 5, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

尿路癌的外科免疫疗法:AMBASSADOR绘制了前进的道路

Kriti Mittal¹, Monika Joshi²

¹University of Massachusetts Medical Center, Worcester, MA, USA.

Med (New York, N.Y.)

|December 14, 2024

概括

辅助 pembrolizumab 显著改善了高风险肌肉侵入性尿路细胞癌患者的无病生存率. 这一发现为护理提供了新的标准,影响了未来的术后免疫疗法策略.

科学领域:

在瘤学瘤学.
尿癌研究尿癌研究
免疫治疗是一种免疫疗法.

背景情况:

肌肉侵入性泌尿腺癌 (MIUC) 具有高复发风险.
辅助疗法旨在减少手术后癌症复发.
以前的试验探讨了辅助环境中的免疫疗法,结果各不相同.

研究的目的:

分析AMBASSADOR试验结果的临床影响.
在CheckMate-274和NIAGARA试验的现有数据中将辅助剂 pembrolizumab 置于背景.
在MIUC.中提出术后免疫治疗的未来方向.

主要方法:

对临床试验数据的审查,特别是AMBASSADOR试验.
辅助药布罗利祖马布与观察的比较分析.
研究结果与CheckMate-274和NIAGARA试验数据的整合.

主要成果:

在AMBASSADOR试验中,随着辅助 pembrolizumab 的使用,改善了无病生存率 (DFS).
与高风险MIUC患者的观察相比, pembrolizumab显示出显著的益处.
这增加了越来越多的证据支持辅助剂环境中的免疫疗法.

结论:

辅助药布罗利祖马布代表了对高风险MIUC的潜在新护理标准.
这些发现需要重新评估当前的治疗模式.
未来的研究应该专注于优化术后免疫疗法策略.

更多相关视频

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...